Better Together: The Benefits of Combining DAX Copilot and Dragon Medical One this National Women’s Health Month
- Kelly
- May 29
- 2 min read
May is recognized as National Women’s Health Month. This month, and every month, it’s important to raise awareness about women’s health issues, promote preventative care, and encourage women to prioritize their well-being. Dragon Medical One and DAX Copilot are the perfect tools to support physicians during this very important month, and throughout the year.
Named #1 Best in KLAS for five consecutive years, Dragon Medical One (DMO) is a trusted speech recognition solution proven to capture clinical notes and navigate systems with ease. DMO helps physicians produce patient notes 45% faster and capture up to 20% more relevant content with 99% accuracy.
DAX Copilot uses its AI technology to automatically capture the patient/physician conversation and turn it into detailed and accurate documentation. When using DAX Copilot, physicians can save up to 7 minutes per visit and reduce documentation time by 50%.
What do these two clinical solutions have in common? They allow physicians to put more focus on the patient and in turn build a deeper connection with them.
Combining DMO and DAX Copilot enhances their features and brings productivity to a whole new level. These solutions work seamlessly with each other, allowing physicians to capture complete patient documentation without touching the EHR.
Before the visit, DMO helps physicians review patient history and complete pre-charting.
During the visit, DAX Copilot captures the relevant parts of the patient/physician conversation and automatically generates a visit summary.
After the visit, DMO allows physicians to complete the post-charting with ease and captures the visit summary to the EHR.
Are you ready to take the next step and elevate your practice? Visit our website to learn more about this next-level combination!
sales@1st-dragon.com | 866-977-3324 | 877-272-8280
Want to stay up to date with the latest news from 1st-Dragon/CME?
コメント